MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Clinical trial NCT00591682 · SUSPENDED
Trial details
- NCT number
- NCT00591682
- Sponsor
- Metastatix, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.